Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauricio Tohen

Showing results (81-90 of 260) with videos related to

Pageof 26
Sort By:
The American Journal of Psychiatry|May 3, 2005
Substance abuse in first-episode bipolar I disorder: indications for early interventionChristopher Baethge, Ross J Baldessarini, Hari-Mandir Kaur Khalsa, et al.
Journal of Depression & Anxiety|November 30, 2013
Negative Affective Features in 516 Cases of First Psychotic Disorder Episodes: Relationship to Suicidal RiskPaola Salvatore, Ross J Baldessarini, Hari-Mandir K Khalsa, et al.
International Clinical Psychopharmacology|December 18, 2010
Relationship between African-American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of AmericaElisabeth K Degenhardt, Jorge M Tamayo, Hassan H Jamal, et al.
The Journal of Clinical Psychiatry|September 13, 2006
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproexJohn P Houston, Jonna Ahl, Adam L Meyers, et al.
Current Medical Research and Opinion|September 24, 2004
Improvement of Positive and Negative Syndrome Scale cognitive score associated with olanzapine treatment of acute maniaLizheng Shi, Leslie M Schuh, Paula T Trzepacz, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studiesMauricio Tohen, Michael Case, Madhukar H Trivedi, et al.
Journal of Affective Disorders|February 19, 2008
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in maniaMichael Berk, Felicity Ng, Wei V Wang, et al.
International Clinical Psychopharmacology|June 10, 2010
Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practiceDiego Novick, Catherine Reed, Josep Maria Haro, et al.
Clinical Therapeutics|March 5, 2004
Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trialLizheng Shi, Madhav A Namjoshi, Ralph Swindle, et al.
Journal of Child and Adolescent Psychopharmacology|July 26, 2003
Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic featuresMelissa P DelBello, Gabrielle A Carlson, Mauricio Tohen, et al.
Pageof 26

Showing results (81-90 of 260) with videos related to

Sort By:
Pageof 26
The American Journal of Psychiatry|May 3, 2005
Substance abuse in first-episode bipolar I disorder: indications for early interventionChristopher Baethge, Ross J Baldessarini, Hari-Mandir Kaur Khalsa, et al.
Journal of Depression & Anxiety|November 30, 2013
Negative Affective Features in 516 Cases of First Psychotic Disorder Episodes: Relationship to Suicidal RiskPaola Salvatore, Ross J Baldessarini, Hari-Mandir K Khalsa, et al.
International Clinical Psychopharmacology|December 18, 2010
Relationship between African-American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of AmericaElisabeth K Degenhardt, Jorge M Tamayo, Hassan H Jamal, et al.
The Journal of Clinical Psychiatry|September 13, 2006
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproexJohn P Houston, Jonna Ahl, Adam L Meyers, et al.
Current Medical Research and Opinion|September 24, 2004
Improvement of Positive and Negative Syndrome Scale cognitive score associated with olanzapine treatment of acute maniaLizheng Shi, Leslie M Schuh, Paula T Trzepacz, et al.
The Journal of Clinical Psychiatry|April 6, 2010
Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studiesMauricio Tohen, Michael Case, Madhukar H Trivedi, et al.
Journal of Affective Disorders|February 19, 2008
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in maniaMichael Berk, Felicity Ng, Wei V Wang, et al.
International Clinical Psychopharmacology|June 10, 2010
Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practiceDiego Novick, Catherine Reed, Josep Maria Haro, et al.
Clinical Therapeutics|March 5, 2004
Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trialLizheng Shi, Madhav A Namjoshi, Ralph Swindle, et al.
Journal of Child and Adolescent Psychopharmacology|July 26, 2003
Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic featuresMelissa P DelBello, Gabrielle A Carlson, Mauricio Tohen, et al.
Pageof 26